Lundberg, Alycen P <br/><br/>
Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species.  [electronic resource] 

 -  Investigational new drugs  04 2017 
 - 134-144 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1573-0646 
<br/><br/><label>Standard No.: </label>10.1007/s10637-016-0414-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>8-Hydroxy-2'-Deoxyguanosine<br/>A549 Cells<br/>Animals<br/>Antineoplastic Agents--adverse effects<br/>Carcinoma, Squamous Cell--blood<br/>Cats<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Deoxyguanosine--analogs & derivatives<br/>Female<br/>HEK293 Cells<br/>Humans<br/>Mouth Neoplasms--blood<br/>NAD(P)H Dehydrogenase (Quinone)--metabolism<br/>Quinones--adverse effects